 Medscape | Hope on Horizon for Type 1 Diabetes Reversal - Medscape Medscape Dr. Pozzilli said that cyclosporine is being reexamined as a possible immune-tolerance agent. It had fallen out of favor in type 1 trials due to concerns about renal toxicity, but since then data suggest that low doses for up to 1 year will help avoid ... |
